A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study
Titel:
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study
Auteur:
Vici, P. Brandi, M. Giotta, F. Foggi, P. Schittulli, F. Di Lauro, L. Gebbia, N. Massidda, B. Filippelli, G. Giannarelli, D. Di Benedetto, A. Mottolese, M. Colucci, G. Lopez, M.